Systematic screening for diabetic retinopathy justified

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.268, 2000-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacologic therapy for diabetic retinopathy

By Speicher Matthew A   Danis Ronald P   Criswell Mark   Pratt Linda  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 239-250

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for diabetic retinopathy

By Schwartz Stephen G   Flynn Harry W   Scott Ingrid U  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. : 1123-1131

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for diabetic retinopathy

By Mohamed Quresh   Wong Tien Y  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 675-694

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for diabetic retinopathy

By Pipis Antonios   Scholl Stefan   Augustin Albert J  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 669-681

Informa Healthcare

Access to resources Recommend Favorite

Pharmacologic Vitreolysis in Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 406-409

Bentham Science Publishers

Access to resources Recommend Favorite